期刊文献+

标准四联疗法及抗生素序贯疗法治疗幽门螺杆菌阳性胃溃疡的效果比较 被引量:4

Comparison of effects of standard quadruple therapy and antibiotic sequential therapy in treatment of Helicobacter pylori-positive gastric ulcer
下载PDF
导出
摘要 目的:比较标准四联疗法及抗生素序贯疗法治疗幽门螺杆菌(Hp)阳性胃溃疡的效果。方法:选取80例Hp阳性胃溃疡患者为研究对象,按随机数字表法分为对照组与研究组各40例,对照组给予标准四联疗法,研究组给予抗生素序贯疗法,比较两组临床疗效、Hp根除率、复发率、治疗前后症状评分及不良反应发生率。结果:研究组治疗总有效率及Hp根除率明显高于对照组,复发率明显低于对照组,差异均有统计学意义(P<0.05);治疗后,两组症状评分均明显降低,且研究组明显低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:抗生素序贯疗法治疗Hp阳性胃溃疡患者可提高治疗总有效率和Hp根除率,降低复发率和症状评分,效果优于标准四联疗法治疗效果。 Objective: To compare effects of standard quadruple therapy and antibiotic sequential therapy in treatment of Helicobacter pylori(Hp)-positive gastric ulcer. Methods: 80 patients with Hp-positive gastric ulcer were selected as the research objects, and were divided into control group and study group by using the random number table method, 40 cases in each. The control group was given the standard quadruple therapy, while the study group used the sequential therapy. Then, the clinical efficacy, Hp eradication rate, recurrence rate, symptom scores before and after the treatment and incidence of adverse reactions were compared between the two groups. Results: The total effective rate and Hp eradication rate of the study group were significantly higher than those of the control group, the recurrence rate was significantly lower than that of the control group, and the differences were statistically significant(P<0.05). After the treatment, the symptom scores of the two groups were significantly reduced;those of the study group were significantly lower than those of the control group;and the differences were statistically significant(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05). Conclusions: For the patients with Hp-positive gastric ulcer, the antibiotic sequential therapy can improve the total effective rate and Hp eradication rate and reduce the recurrence rate and symptom score. Moreover, it is superior to the standard quadruple therapy.
作者 王春伟 WANG Chunwei(Panjin City People’s Hospital,Panjin 124000 Liaoning,China)
机构地区 盘锦市人民医院
出处 《中国民康医学》 2020年第5期6-7,10,共3页 Medical Journal of Chinese People’s Health
关键词 胃溃疡 标准四联疗法 幽门螺杆菌阳性 序贯疗法 Gastric ulcer Standard quadruple therapy Helicobacter pylori positive Sequential therapy
  • 相关文献

参考文献8

二级参考文献58

  • 1余艳秋,王建宁,翟启智,朱祖明,王川.含左氧氟沙星的四联药物10日序贯疗法根除幽门螺杆菌疗效观察[J].山东医药,2013,53(30):64-65. 被引量:20
  • 2张林,王江滨.幽门螺杆菌根除治疗失败原因分析[J].中华消化杂志,2005,25(2):124-126. 被引量:99
  • 3张小晋,程远,王王己.NSAIDs在幽门螺杆菌相关性胃黏膜病变中的作用[J].胃肠病学和肝病学杂志,2006,15(1):32-34. 被引量:5
  • 4成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 5SHAH A, JAVID G, ZARGAR S A, et al. Safety and efficacy of 1-week levofloxaein-based triple therapy in first-line treatment for Helicobaeter pylori-related pep- tic ulcer disease in Kashmir, India[J]. Indian J Gastro- enterl,2013,32: 32- 36.
  • 6MALFERTHEINER P, MEGRAUD F, O'MORAIN C A,et al. Management of Helicobacter py!ori the Maastri-cht IV/florence consensus reportEJT. Gut,2012,61:646-664.
  • 7张刚.四联10日序贯疗法根除幽门螺杆菌感染的疗效观察[J].医学信息,2015,增刊:394-394.
  • 8Malfertheiner P, Bazzoli F, Delchier JC, et al. Helieobacter pylori eradication with a capsule containing bismuth sub- citrate potassium, metronidazole, and tetracycline given with omeprazole versus elarithromycin-based triple thera- py: a randomised, open-label, non-inferiority, phase 3 trial [J]. Lancet,2011,377(9769) :905-913.
  • 9Graham DY, Lu H, Yamaoka Y. A report card to grade helicobacter pylori therapy [J]. Helicobacter, 2007, 12 (4) :275-278.
  • 10De Francesco V, Zullo A, Hassan C, et al. Two new treat- ment regimens for Helicobacter pylori eradication: a ran- domised study[J]. Dig Liver Dis, 2001,33 (8) .. 676-679.

共引文献282

同被引文献40

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部